Advertisement
Advertisement

GKOS

GKOS logo

Glaukos Corporation

116.46
USD
Sponsored
-2.99
-2.50%
Apr 10, 15:59 UTC -4
Closed
exchange

After-Market

116.41

-0.05
-0.05%

GKOS Earnings Reports

Positive Surprise Ratio

GKOS beat 28 of 41 last estimates.

68%

Next Report

Date of Next Report
Apr 29, 2026
Estimate for Q1 26 (Revenue/ EPS)
$139.62M
/
-$0.27
Implied change from Q4 25 (Revenue/ EPS)
-2.44%
/
-3.57%
Implied change from Q1 25 (Revenue/ EPS)
+30.90%
/
+22.73%

Glaukos Corporation earnings per share and revenue

On Feb 17, 2026, GKOS reported earnings of -0.28 USD per share (EPS) for Q4 25, missing the estimate of -0.20 USD, resulting in a -39.93% surprise. Revenue reached 143.12 million, compared to an expected 139.12 million, with a 2.87% difference. The market reacted with a -5.26% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 15 analysts forecast an EPS of -0.27 USD, with revenue projected to reach 139.62 million USD, implying an decrease of -3.57% EPS, and decrease of -2.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
logo
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
logo
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
logo
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
logo
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
logo
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
For Q4 2025, Glaukos Corporation reported EPS of -$0.28, missing estimates by -39.93%, and revenue of $143.12M, 2.87% above expectations.
The stock price moved down -5.26%, changed from $110.23 before the earnings release to $104.43 the day after.
The next earning report is scheduled for Apr 29, 2026.
Based on 15 analysts, Glaukos Corporation is expected to report EPS of -$0.27 and revenue of $139.62M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement